A2 GUM Post-Market Effectiveness Study
赞助:
Nestlé
合作者:
信息的提供 (责任方):
,
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | October 4, 2018 | ||
首次发布日期e ICMJE | October 5, 2018 | ||
最后更新发布日期 | October 5, 2018 | ||
预计研究开始日期 ICMJE | September 15, 2018 | ||
预计主要完成日期 | December 31, 2018 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Overall digestive comfort[ Time Frame: Baseline to Study Day 14 ] Toddler Gut Comfort score from parent-reported questionnaire |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | A2 GUM Post-Market Effectiveness Study | ||
正式标题 ICMJE | Real-World Effectiveness Study of A2 Growing Up Milk (GUM) Among Young and Pre-School Age Toddlers in China | ||
简要概况 | This is a post-market, real-life effectiveness study of A2 growing up milk on toddlers' gut comfort. |
||
详细说明 | This post-market study primarily aims to assess the real-life effectiveness of a newly-launched A2 milk on toddlers' gut comfort via evaluating individual GI symptoms and GI-related behaviors compared with other milk products and milk alternatives. | ||
研究类型 ICMJE | Interventional | ||
研究阶段 | N/A | ||
研究设计 ICMJE | 分配: Randomized 干预模型: Parallel Assignment 干预模型描述: 盲法: Interventional 盲法描述: 主要目的: Prevention |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Recruiting | ||
预计入组 ICMJE |
360 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | December 31, 2018 | ||
预计主要完成日期 | December 31, 2018 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion Criteria: - Having obtained his / her parents' (or his or her legally accepted guardian written informed consent and having evidence of personally signed and dated informed consent document indicating that the child's parent(s) / legal guardian has been informed of all pertinent aspects of the study. - Children 12 - 36 months of age at enrolment. - Children who have been born full-term (≥ 37 completed weeks of gestation) and having a birth weight ≥ 2.5 kg and ≤ 4.5 kg. - Children who are habitually consuming some cow's milk, other traditional milks (including non-A2 GUMs, kids' milk, white milk, flavored milk) and/or dairy or non-dairy alternative milks (such as those sourced from goats, sheep, soy, rice, coconut, and nut). - Child's parent(s) / guardian is of legal age of consent, has sufficient command of Chinese (Mandarin) language to complete the informed consent and other study documents, is willing and able to fulfill the requirements of the study protocol. Exclusion Criteria: - Chronic infectious, metabolic, genetic illness or other disease including any condition that impacts feeding or may impact outcome measures. - Known and diagnosed cow's milk protein allergy. - Children currently using or having ever used specialty infant formula and/or GUMs such as hypoallergenic (HA), lactose-free, or anti-regurgitation formulas. - Children who have known cognitive and developmental disorders. | ||
性别 |
|
||
年龄 | 最小年龄:12 Months ,最大年龄:36 Months | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | China | ||
管理信息 | 数据检测委员会 | No | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | , | ||
研究赞助商 ICMJE | Nestlé | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | |||
验证日期 | October 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |
请使用微信扫码报名